结合突变的大型核糖体子单元的MLSBK抗生素的结构为耐药性的结构性解释提供了解释
Daqi Tu1, Gregor Blaha, Peter B Moore
1Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06520, USA.
Cell
|April 27, 2005
概括
细菌核糖体中的突变,如G2099A,通过改变药物结合,赋予对宏类抗生素的耐药性. 了解这些结构变化可以解释细菌对抗生素耐药性的机制.
科学领域:
- 结构生物学 结构生物学
- 微生物学 微生物学
- 生物化学 生物化学
背景情况:
- 抗生素耐药性是一个日益严重的全球健康问题.
- 宏类抗生素对于治疗细菌感染至关重要.
- 核糖体突变可以赋予抗生素的耐药性.
研究的目的:
- 阐明细菌核糖体中抗生素耐药性的结构基础.
- 解释宏化物和其他抗生素与突变的核糖体子单元的差异性结合.
主要方法:
- 使用X射线晶体学来确定与结合抗生素的突变核糖体子单元的结构.
- 进行了比较结构分析,以了解药物与核糖体相互作用.
主要成果:
- 在H. marismortui中的G2099A突变 (在大肠杆菌中的A2058G) 显著改变了类结合,特别是对于红红素,解释了耐药性.
- 突变对阿兹罗米辛的结合影响很小,而由于溶解效应,红色素的亲和力会大幅增加.
- 链条蛋白A和B的协同结合涉及对核糖体基A2103 (大肠杆菌中的A2062) 的重定位.
- 核糖体蛋白L22中的缺失突变改变了出口道的形状,导致了宏类耐药性.
结论:
- 核糖体结构和特定突变是宏类抗生素疗效的关键决定因素.
- 了解这些结构功能关系可以指导开发新的抗生素和打击耐药性的策略.
相关概念视频
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


